Burkina Faso [clinicaltrials_resource:28814f84db09b59b95f863b9c143c3a9]
clinicaltrials:NCT00116350Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME) [clinicaltrials:NCT00122538]Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance [clinicaltrials:NCT00140517]Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding [clinicaltrials:NCT00158509]Impact of Insecticide-Treated Curtains on Antimalarial Drug Resistance [clinicaltrials:NCT00169078]Effects of Insecticide Treated Bednets on Child Morbidity and Mortality [clinicaltrials:NCT00225368]Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina Faso [clinicaltrials:NCT00261222]Effectiveness and Cost-Effectiveness of a Rapid Diagnostic Test for Malaria [clinicaltrials:NCT00317590]Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria [clinicaltrials:NCT00344006]Safety and Efficacy of Methylene Blue Combined With Artesunate or Amodiaquine for Malaria Treatment in Children of Burkina Faso: a Pilot Study [clinicaltrials:NCT00354380]Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria. [clinicaltrials:NCT00367653]Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria [clinicaltrials:NCT00371735]clinicaltrials:NCT00393679clinicaltrials:NCT00397150clinicaltrials:NCT00403260clinicaltrials:NCT00452088Schistosomiasis in Women of Reproductive Age in Burkina Faso: Implications for Control [clinicaltrials:NCT00463632]Plasmodium Resistance in A. Gambiae [clinicaltrials:NCT00466557]Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion [clinicaltrials:NCT00466999]Different Approaches for Delivery of IPT in Pregnancy in Burkina Faso [clinicaltrials:NCT00494416]Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients [clinicaltrials:NCT00541385]Safety and Efficacy of Methylene Blue Combined With Amodiaquine or Artesunate for Malaria Treatment in Children of Burkina Faso [clinicaltrials:NCT00545935]Effect of Iron Versus Multiple Micronutrient Supplementation on Anemia in Preschool Children of Malaria-Endemic Area [clinicaltrials:NCT00628459]Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding [clinicaltrials:NCT00640263]Prevention of Intrauterine Growth Retardation in Hounde District, Burkina Faso [clinicaltrials:NCT00642408]Misoprostol for the Treatment of Incomplete Abortion [clinicaltrials:NCT00670761]clinicaltrials:NCT00677833Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria Component [clinicaltrials:NCT00680732]Pharmacokinetic of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in Pregnancy [clinicaltrials:NCT00701961]New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural Africa [clinicaltrials:NCT00730366]A Trial of the Combined Impact of Intermittent Preventive Treatment and Insecticide Treated Bednets in Reducing Morbidity From Malaria in African Children [clinicaltrials:NCT00738946]clinicaltrials:NCT00808951clinicaltrials:NCT00852423Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa [clinicaltrials:NCT00866619]clinicaltrials:NCT00909974Efficacy of Methylene Blue for Malaria Treatment in Adults of Burkina Faso: Proof of Principle Study in Semi-Immune Adults of Burkina Faso in the Frame of the A8 Project of the SFB 544 [clinicaltrials:NCT00917202]Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé) [clinicaltrials:NCT00928187]Dihydroartemisinin (DHA)-Piperaquine for IPT to Prevent Malaria in Children in Burkina Faso [clinicaltrials:NCT00941785]clinicaltrials:NCT00944281Impact of Preventive and Therapeutic Zinc Supplementation Programs Among Young Children [clinicaltrials:NCT00944359]
country [clinicaltrials_vocabulary:country]
Burkina Faso [clinicaltrials_resource:28814f84db09b59b95f863b9c143c3a9]
Bio2RDF identifier
28814f84db09b59b95f863b9c143c3a9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:28814f84db09b59b95f863b9c143c3a9
identifier
clinicaltrials_resource:28814f84db09b59b95f863b9c143c3a9
title
Burkina Faso
@en
type
label
Burkina Faso [clinicaltrials_resource:28814f84db09b59b95f863b9c143c3a9]
@en